Literature DB >> 8143877

The actin binding site in the tail domain of Dictyostelium myosin IC (myoC) resides within the glycine- and proline-rich sequence (tail homology region 2).

G Jung1, J A Hammer.   

Abstract

The majority of protozoan myosins I possess tail domains composed of three distinct and conserved regions of sequence, referred to as tail homology regions 1, 2 and 3 (TH.1, TH.2 and TH.3). While the N-terminal approximately half of the tail (corresponding to TH.1) has been implicated in membrane binding, all or some portion of the C-terminal approximately half of the tail (corresponding to TH.2 plus TH.3) has been implicated in binding to F-actin in a nucleotide-insensitive fashion. Here we show, using fusion proteins containing portions of the Dictyostelium myosin IC (myoC) tail domain and F-actin sedimentation assays, that the ability of the myoC tail to bind to actin resides entirely within the glycine- and proline-rich TH.2 domain. The src-like TH.3 domain does not bind to actin, nor does it augment the binding properties of the TH.2 domain. In addition to defining more precisely the location of the actin binding site in the tail domain of a protozoan myosin I, these results have implications for the function of the src-like TH.3 domain in myosins I and other proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143877     DOI: 10.1016/0014-5793(94)80500-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  A dibasic motif in the tail of a class XIV apicomplexan myosin is an essential determinant of plasma membrane localization.

Authors:  C Hettmann; A Herm; A Geiter; B Frank; E Schwarz; T Soldati; D Soldati
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

2.  Myosin I contributes to the generation of resting cortical tension.

Authors:  J Dai; H P Ting-Beall; R M Hochmuth; M P Sheetz; M A Titus
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

3.  Functional characterization of myosin I tail regions in Candida albicans.

Authors:  Ursula Oberholzer; Tatiana L Iouk; David Y Thomas; Malcolm Whiteway
Journal:  Eukaryot Cell       Date:  2004-10

4.  Unconventional myosins at the crossroad of signal transduction and cytoskeleton remodeling.

Authors:  T Soldati; E C Schwarz; H Geissler
Journal:  Protoplasma       Date:  1999       Impact factor: 3.356

Review 5.  A myosin family reunion.

Authors:  J R Sellers; H V Goodson; F Wang
Journal:  J Muscle Res Cell Motil       Date:  1996-02       Impact factor: 2.698

6.  The myosin I SH3 domain and TEDS rule phosphorylation site are required for in vivo function.

Authors:  K D Novak; M A Titus
Journal:  Mol Biol Cell       Date:  1998-01       Impact factor: 4.138

7.  p21-activated kinase has substrate specificity similar to Acanthamoeba myosin I heavy chain kinase and activates Acanthamoeba myosin I.

Authors:  H Brzeska; U G Knaus; Z Y Wang; G M Bokoch; E D Korn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

8.  The novel adaptor protein, Mti1p, and Vrp1p, a homolog of Wiskott-Aldrich syndrome protein-interacting protein (WIP), may antagonistically regulate type I myosins in Saccharomyces cerevisiae.

Authors:  Junko Mochida; Takaharu Yamamoto; Konomi Fujimura-Kamada; Kazuma Tanaka
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

9.  Localization of a class III myosin to filopodia tips in transfected HeLa cells requires an actin-binding site in its tail domain.

Authors:  F Les Erickson; Amoreena C Corsa; Andrea C Dose; Beth Burnside
Journal:  Mol Biol Cell       Date:  2003-07-25       Impact factor: 4.138

10.  A myosin IK-Abp1-PakB circuit acts as a switch to regulate phagocytosis efficiency.

Authors:  Régis Dieckmann; Yosuke von Heyden; Claudia Kistler; Navin Gopaldass; Stéphanie Hausherr; Scott William Crawley; Eva C Schwarz; Ralph P Diensthuber; Graham P Côté; Georgios Tsiavaliaris; Thierry Soldati
Journal:  Mol Biol Cell       Date:  2010-03-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.